Aster Capital Management (Difc) LTD Tarsus Pharmaceuticals, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 218 shares of TARS stock, worth $11,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
218Holding current value
$11,041% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
200Shares Held
40.4MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$165 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$164 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$128 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$127 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$114 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.35B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...